WallStSmart

Cementos Pacasmayo SAA ADR (CPAC)vsCemex SAB de CV ADR (CX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Cemex SAB de CV ADR generates 661% more annual revenue ($16.54B vs $2.17B). CPAC leads profitability with a 8.4% profit margin vs 2.7%. CX appears more attractively valued with a PEG of 0.11. CPAC earns a higher WallStSmart Score of 66/100 (B-).

CPAC

Strong Buy

66

out of 100

Grade: B-

Growth: 6.7Profit: 7.0Value: 6.7Quality: 5.0
Piotroski: 5/9Altman Z: 1.59

CX

Buy

54

out of 100

Grade: C-

Growth: 4.0Profit: 5.0Value: 6.7Quality: 4.5
Piotroski: 4/9Altman Z: 1.48
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CPACUndervalued (+13.6%)

Margin of Safety

+13.6%

Fair Value

$12.61

Current Price

$10.40

$2.21 discount

UndervaluedFair: $12.61Overvalued
CXUndervalued (+1.1%)

Margin of Safety

+1.1%

Fair Value

$13.12

Current Price

$12.47

$0.65 discount

UndervaluedFair: $13.12Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CPAC4 strengths · Avg: 8.5/10
EPS GrowthGrowth
55.6%10/10

Earnings expanding 55.6% YoY

P/E RatioValuation
16.7x8/10

Attractively priced relative to earnings

Price/BookValuation
2.4x8/10

Reasonable price relative to book value

Operating MarginProfitability
25.1%8/10

Strong operational efficiency at 25.1%

CX2 strengths · Avg: 10.0/10
PEG RatioValuation
0.1110/10

Growing faster than its price suggests

Price/BookValuation
1.4x10/10

Reasonable price relative to book value

Areas to Watch

CPAC3 concerns · Avg: 3.3/10
Altman Z-ScoreHealth
1.594/10

Distress zone — elevated risk

Market CapQuality
$886.62M3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.133/10

Elevated debt levels

CX4 concerns · Avg: 3.0/10
P/E RatioValuation
37.1x4/10

Premium valuation, high expectations priced in

Return on EquityProfitability
3.5%3/10

ROE of 3.5% — below average capital efficiency

Profit MarginProfitability
2.7%3/10

2.7% margin — thin

EPS GrowthGrowth
-67.5%2/10

Earnings declined 67.5%

Comparative Analysis Report

WallStSmart Research

Bull Case : CPAC

The strongest argument for CPAC centers on EPS Growth, P/E Ratio, Price/Book. Revenue growth of 11.3% demonstrates continued momentum. PEG of 1.13 suggests the stock is reasonably priced for its growth.

Bull Case : CX

The strongest argument for CX centers on PEG Ratio, Price/Book. Revenue growth of 11.2% demonstrates continued momentum. PEG of 0.11 suggests the stock is reasonably priced for its growth.

Bear Case : CPAC

The primary concerns for CPAC are Altman Z-Score, Market Cap, Debt/Equity.

Bear Case : CX

The primary concerns for CX are P/E Ratio, Return on Equity, Profit Margin. Thin 2.7% margins leave little buffer for downturns.

Key Dynamics to Monitor

CX carries more volatility with a beta of 0.83 — expect wider price swings.

CPAC is growing revenue faster at 11.3% — sustainability is the question.

CX generates stronger free cash flow (31M), providing more financial flexibility.

Monitor BUILDING MATERIALS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CPAC scores higher overall (66/100 vs 54/100) and 11.3% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cementos Pacasmayo SAA ADR

BASIC MATERIALS · BUILDING MATERIALS · USA

Cementos Pacasmayo SAA, a cement company, produces, distributes and sells cement and cement-related materials in Peru. The company is headquartered in Lima, Peru.

Cemex SAB de CV ADR

BASIC MATERIALS · BUILDING MATERIALS · USA

CEMEX, SAB de CV, produces, markets, distributes and sells cement, ready-mix concrete, aggregates, clinker and other construction materials worldwide. The company is headquartered in San Pedro Garza Garca, Mexico.

Want to dig deeper into these stocks?